Display Options:

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Colorectal Neoplasms; Multiple Myeloma; Severe Acute Respiratory Syndrome; Thymoma; Breast Neoplasms; Heart Failure; Respiratory Tract Diseases; Liver Neoplasms; Thyroid Neoplasms

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Alzheimer Disease; Anemia, Sickle Cell; Hodgkin Disease; Hyperphosphatemia; Lymphoma, Non-Hodgkin; Multiple Sclerosis; Ataxia Telangiectasia; Carcinoma, Basal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Depressive Disorder; Friedreich Ataxia; Leukemia, Lymphocytic, Chronic, B-Cell; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Malnutrition; Neurodegenerative Diseases; Polycystic Kidney Diseases; Pre-Eclampsia; Psoriasis; Diabetic Neuropathies; Jaundice, Obstructive; Renal Insufficiency, Chronic; Urinary Bladder Neoplasms; Acne Vulgaris; Anemia; Anemia, Iron-Deficiency; Folic Acid Deficiency

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Alzheimer Disease; Diabetes Mellitus; Insulin Resistance; Supranuclear Palsy, Progressive; Anemia; Atherosclerosis; Diabetes Mellitus, Type 2; Metabolic Syndrome; Obesity; Polycystic Ovary Syndrome; Fever; Pain

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Retinoid X receptor alpha antagonist
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Constipation

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Investigational
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Anxiety; Dementia; Depressive Disorder; Schizophrenia; Cardiovascular Diseases

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Monoamine oxidase inhibitor
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: GABA-A receptor; anion channel positive allosteric modulator
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Coronary Disease; Dementia; Premature Birth; Radiation Pneumonitis; Myocardial Infarction; Severe Acute Respiratory Syndrome; Cardiovascular Diseases

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: INJECTION; ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Arthritis, Rheumatoid; Hepatitis B, Chronic; Prostatic Neoplasms, Castration-Resistant; Glioblastoma; Osteoporosis, Postmenopausal; Renal Insufficiency, Chronic; Cardiovascular Diseases; Osteoporosis; Celiac Disease; Colitis, Ulcerative; Cystic Fibrosis; Fibrosis; Hemorrhage; Vitamin K Deficiency

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Postpartum Hemorrhage

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Pain; Breast Neoplasms; Arthralgia; Myalgia; Rheumatic Diseases

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Investigational
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Carcinoma, Squamous Cell

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Alcohol dehydrogenase inhibitor
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Melatonin receptor agonist
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Brain Ischemia; Enterocolitis, Necrotizing; Hot Flashes; Hypoxia-Ischemia, Brain; Metabolic Diseases; Multiple Sclerosis; Neonatal Sepsis; Periodontal Diseases; Postpartum Hemorrhage; Sepsis; Skin Diseases; Stomatitis; Substance Withdrawal Syndrome; Sunburn; Alcohol-Related Disorders; Aortic Aneurysm; Atrial Fibrillation; Autistic Disorder; Burns; Cognitive Dysfunction; Colitis, Ulcerative; Dengue; Depressive Disorder, Major; Dermatitis, Atopic; Enuresis; Epilepsy; Essential Hypertension; Fatigue; Fibromyalgia; Head and Neck Neoplasms; Hemorrhage; Hypertension; Melanoma; Metabolic Syndrome; Multiple Sclerosis, Relapsing-Remitting; Myocardial Infarction; Pain; Parkinson Disease; Periodontitis; Prediabetic State; Reperfusion Injury; Severe Acute Respiratory Syndrome; Wounds and Injuries; Acute Kidney Injury; Anxiety; Attention Deficit Disorder with Hyperactivity; Barrett Esophagus; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Child Development Disorders, Pervasive; Delirium; Dementia; Depressive Disorder; Gastroesophageal Reflux; Irritable Bowel Syndrome; Migraine Disorders; Neoplasms; Schizophrenia; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Squamous Cell Carcinoma of Head and Neck; Tooth Diseases

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Hypersensitivity

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Investigational
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Epilepsy; Anxiety; Dementia; Depressive Disorder; Schizophrenia; Sleep Wake Disorders

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Fever; Pain

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Diagnostic agent
ROUTE OF ADMINISTRATION: INJECTION; URETERAL; URETHRAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Ileus

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Voltage-gated L-type calcium channel blocker
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Hypertension; Cardiovascular Diseases

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Irritable Bowel Syndrome; Digestive System Diseases

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Opioid receptors; mu/kappa/delta agonist
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Pain

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Brain Injuries; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Gastroschisis; Hypoglycemia; Infections; Mycoses; Pneumonia; Respiratory Insufficiency; Spinal Cord Injuries; Amyotrophic Lateral Sclerosis; Biliary Tract Neoplasms; Common Cold; Gastroparesis; Hearing Loss; Hyperkalemia; Hyperlipidemias; Hypospadias; Ischemic Stroke; Low Back Pain; Malnutrition; Metabolic Diseases; Obesity; Osteoarthritis; Porphyrias; Postpartum Hemorrhage; Schizophrenia; Temporomandibular Joint Disorders; Tendinopathy; Vaginosis, Bacterial; Angina, Unstable; Breast Neoplasms; Carcinoma, Hepatocellular; Epilepsy; Heart Failure; Hyponatremia; Ileus; Liver Diseases; Multiple Sclerosis; Myocardial Infarction; Neutropenia; Pain; Postoperative Nausea and Vomiting; Renal Insufficiency, Chronic; Sepsis; Severe Acute Respiratory Syndrome; Shock, Septic; Tennis Elbow; Hemorrhage; Varicose Veins

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Fever; Pain

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Depressive Disorder; Hypotension, Orthostatic; Inflammation; Radiodermatitis; Acute Lung Injury; Brain Injuries; Cognitive Dysfunction; Heart Diseases; Hernias, Diaphragmatic, Congenital; Hypotension; Sepsis; Shock; Shock, Septic; Cardiovascular Diseases

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: DNA polymerase catalytic subunit inhibitor
ROUTE OF ADMINISTRATION: Unknown
STATUS: Investigational
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Herpes Zoster; Neuralgia, Postherpetic

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Sodium/glucose cotransporter 1 inhibitor
ROUTE OF ADMINISTRATION: Unknown
STATUS: Investigational
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Kidney Diseases; Liver Diseases; Heart Failure; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Myeloma; Cough

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Cardiovascular Diseases